Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Research Report 2021

1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Overview
    1.1 Product Overview and Scope of Benign Prostatic Hyperplasia (BPH) Treatment Devices
    1.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Type
        1.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Surgical Treatment
        1.2.3 Minimally Invasive Treatment
        1.2.4 Laser Treatment
        1.2.5 Other
    1.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Application
        1.3.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Comparison by Application: (2021-2027)
        1.3.2 Fertility Clinics
        1.3.3 Hospitals
        1.3.4 Others
    1.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Estimates and Forecasts
        1.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue 2016-2027
        1.4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2016-2027
        1.4.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competition by Manufacturers
    2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Sites, Area Served, Product Type
    2.5 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competitive Situation and Trends
        2.5.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Benign Prostatic Hyperplasia (BPH) Treatment Devices Players Market Share by Revenue
        2.5.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Retrospective Market Scenario by Region
    3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures by Country
        3.3.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
        3.3.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures by Country
        3.4.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
        3.4.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures by Region
        3.5.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region
        3.5.2 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures by Country
        3.6.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
        3.6.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures by Country
        3.7.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
        3.7.2 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Analysis by Type
    4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2021)
    4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Type (2016-2021)
    4.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2016-2021)

5 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Analysis by Application
    5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2021)
    5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Application (2016-2021)
    5.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Advin Urology
        6.1.1 Advin Urology Corporation Information
        6.1.2 Advin Urology Description and Business Overview
        6.1.3 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Advin Urology Product Portfolio
        6.1.5 Advin Urology Recent Developments/Updates
    6.2 Biolitec
        6.2.1 Biolitec Corporation Information
        6.2.2 Biolitec Description and Business Overview
        6.2.3 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Biolitec Product Portfolio
        6.2.5 Biolitec Recent Developments/Updates
    6.3 Boston Scientific Corporation
        6.3.1 Boston Scientific Corporation Corporation Information
        6.3.2 Boston Scientific Corporation Description and Business Overview
        6.3.3 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Boston Scientific Corporation Product Portfolio
        6.3.5 Boston Scientific Corporation Recent Developments/Updates
    6.4 CONMED
        6.4.1 CONMED Corporation Information
        6.4.2 CONMED Description and Business Overview
        6.4.3 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 CONMED Product Portfolio
        6.4.5 CONMED Recent Developments/Updates
    6.5 Convergent Laser Technologies
        6.5.1 Convergent Laser Technologies Corporation Information
        6.5.2 Convergent Laser Technologies Description and Business Overview
        6.5.3 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Convergent Laser Technologies Product Portfolio
        6.5.5 Convergent Laser Technologies Recent Developments/Updates
    6.6 CoreTherm Medical, Inc. (ProstaLund)
        6.6.1 CoreTherm Medical, Inc. (ProstaLund) Corporation Information
        6.6.2 CoreTherm Medical, Inc. (ProstaLund) Description and Business Overview
        6.6.3 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 CoreTherm Medical, Inc. (ProstaLund) Product Portfolio
        6.6.5 CoreTherm Medical, Inc. (ProstaLund) Recent Developments/Updates
    6.7 HistoSonics, Inc.
        6.6.1 HistoSonics, Inc. Corporation Information
        6.6.2 HistoSonics, Inc. Description and Business Overview
        6.6.3 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 HistoSonics, Inc. Product Portfolio
        6.7.5 HistoSonics, Inc. Recent Developments/Updates
    6.8 JenaSurgical GmbH
        6.8.1 JenaSurgical GmbH Corporation Information
        6.8.2 JenaSurgical GmbH Description and Business Overview
        6.8.3 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 JenaSurgical GmbH Product Portfolio
        6.8.5 JenaSurgical GmbH Recent Developments/Updates
    6.9 KARL STORZ
        6.9.1 KARL STORZ Corporation Information
        6.9.2 KARL STORZ Description and Business Overview
        6.9.3 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 KARL STORZ Product Portfolio
        6.9.5 KARL STORZ Recent Developments/Updates
    6.10 LISA Laser Products GmbH
        6.10.1 LISA Laser Products GmbH Corporation Information
        6.10.2 LISA Laser Products GmbH Description and Business Overview
        6.10.3 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 LISA Laser Products GmbH Product Portfolio
        6.10.5 LISA Laser Products GmbH Recent Developments/Updates
    6.11 Lumenis Ltd.
        6.11.1 Lumenis Ltd. Corporation Information
        6.11.2 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
        6.11.3 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Lumenis Ltd. Product Portfolio
        6.11.5 Lumenis Ltd. Recent Developments/Updates
    6.12 Medifocus, Inc.
        6.12.1 Medifocus, Inc. Corporation Information
        6.12.2 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
        6.12.3 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Medifocus, Inc. Product Portfolio
        6.12.5 Medifocus, Inc. Recent Developments/Updates
    6.13 Endo International
        6.13.1 Endo International Corporation Information
        6.13.2 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
        6.13.3 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Endo International Product Portfolio
        6.13.5 Endo International Recent Developments/Updates
    6.14 Medtronic
        6.14.1 Medtronic Corporation Information
        6.14.2 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
        6.14.3 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Medtronic Product Portfolio
        6.14.5 Medtronic Recent Developments/Updates
    6.15 Siemens
        6.15.1 Siemens Corporation Information
        6.15.2 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
        6.15.3 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 Siemens Product Portfolio
        6.15.5 Siemens Recent Developments/Updates
    6.16 Olympus
        6.16.1 Olympus Corporation Information
        6.16.2 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
        6.16.3 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 Olympus Product Portfolio
        6.16.5 Olympus Recent Developments/Updates
    6.17 Urologix
        6.17.1 Urologix Corporation Information
        6.17.2 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
        6.17.3 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 Urologix Product Portfolio
        6.17.5 Urologix Recent Developments/Updates
    6.18 NeoTract
        6.18.1 NeoTract Corporation Information
        6.18.2 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
        6.18.3 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.18.4 NeoTract Product Portfolio
        6.18.5 NeoTract Recent Developments/Updates
    6.19 Urotech
        6.19.1 Urotech Corporation Information
        6.19.2 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
        6.19.3 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.19.4 Urotech Product Portfolio
        6.19.5 Urotech Recent Developments/Updates
    6.20 Baxter International
        6.20.1 Baxter International Corporation Information
        6.20.2 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Description and Business Overview
        6.20.3 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.20.4 Baxter International Product Portfolio
        6.20.5 Baxter International Recent Developments/Updates

7 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Cost Analysis
    7.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
    7.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors List
    8.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Customers

9 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Dynamics
    9.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Trends
    9.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Growth Drivers
    9.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Challenges
    9.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Restraints

10 Global Market Forecast
    10.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2022-2027)
    10.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application (2022-2027)
    10.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer